Ligita Jančorienė
Biographic Data
| ID | 7784677 |
|---|---|
| NAME | Ligita Jančorienė |
| GIVEN NAMES | Ligita |
| FAMILY NAME | Jančorienė |
| SIGNATURE | JANČORIENĖ L |
| AFFILIATIONS | Vilnius University |
| ORCID | 0000-0001-6488-6312 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Hepatitis C screening in Lithuania
During the first year of the Lithuanian screening program, GPs were able to screen 44% of the target population. However, the country will not meet elimination targets as it currently stands without increasing treatment levels and lifting fibrosis restrictions
Trends in Incidence and Mortality of Primary Liver Cancer in Lithuania 1998–2015
Background : Recently, reports have suggested that rates of liver cancer have increased during the last decades in developed countries; increasing hepatocellular carcinoma and cholangiocarcinoma rates were reported. The aim of this study was to examine time trends in incidence and mortality rates of liver cancer for the period of 1998-2015 in Lithuania by sex, age, and histology. Methods : We examined the incidence of liver cancer from 1998 to 20…
No prominent works on this page.
Trends in Incidence and Mortality of Primary Liver Cancer in Lithuania 1998–2015
Background : Recently, reports have suggested that rates of liver cancer have increased during the last decades in developed countries; increasing hepatocellular carcinoma and cholangiocarcinoma rates were reported. The aim of this study was to examine time trends in incidence and mortality rates of liver cancer for the period of 1998-2015 in Lithuania by sex, age, and histology. Methods : We examined the incidence of liver cancer from 1998 to 20…
Hepatitis C screening in Lithuania
During the first year of the Lithuanian screening program, GPs were able to screen 44% of the target population. However, the country will not meet elimination targets as it currently stands without increasing treatment levels and lifting fibrosis restrictions
Hepatitis B Virus Studies (2 works) · Internal Medicine (2 works) · Liver Disease Diagnosis and Treatment (2 works) · Medicine (2 works) · Antibody (1 work) · Biostatistics (1 work) · Cancer (1 work) · Cancer registry (1 work) · Demography (1 work) · Demography (1 work)